FMT for prediabetes and insulin resistance: what the trials show
A fasting sugar between 100 and 125 mg/dL usually comes with a warning from your doctor: you have prediabetes. It's the stage where change makes the biggest difference. Several clinical trials have tested whether fecal microbiota transplant (FMT) from lean, healthy donors can improve the way the body responds to insulin. Here is what they found, why diet decided much of the result, and what FMT can't do. This page comes from Resplice Institute, with centres in Hyderabad and Mumbai.
Evidence level 3 of 5
Small randomised trials. See the studies
Can FMT reverse prediabetes?
FMT has not been shown to reverse prediabetes on its own. In several randomised trials, FMT from lean, healthy donors improved insulin sensitivity for around six weeks, and results were best when combined with fibre or lifestyle changes. The effect often faded within a few months. Diet, activity and weight management remain the proven way to bring blood sugar back to normal.
Key points
- Prediabetes means a fasting glucose of 100–125 mg/dL or an HbA1c of 5.7–6.4%.
- In a Dutch trial, glucose uptake rose from 26.2 to 45.3 µmol/kg/min six weeks after lean-donor FMT.
- In a later trial only about half of participants responded, and the benefit had gone by 18 weeks.
- In a Canadian trial, oral FMT capsules improved insulin resistance only when combined with a daily fibre supplement.
- About 15% of Indian adults, roughly 136 million people, have prediabetes.
What is fecal microbiota transplant (FMT)?
Fecal microbiota transplant (FMT), also called faecal microbiota transplantation or a stool transplant, moves a complete community of gut bacteria from a carefully screened, healthy donor into a patient’s bowel. The aim is to rebuild a balanced gut microbiome. It is usually given by colonoscopy or enema; some research studies use capsules.
FMT is an established treatment for recurrent C. difficile infection, where gastroenterology guidelines recommend it for suitable adults.3 For prediabetes and insulin resistance it is still being researched.
FMT for prediabetes at a glance
| Status | Investigational for prediabetes and insulin resistance. |
|---|---|
| Strongest human evidence | Several small randomised trials in people with metabolic syndrome or type 2 diabetes. |
| What changed | Insulin sensitivity improved about six weeks after FMT in donor groups.1 |
| Biggest uncertainty | Benefits were short-lived, and not everyone responded.2 |
| Standard care | Diet, physical activity and weight management, with medicines such as metformin when prescribed. |
| Where FMT fits | Within ethics-approved research or for a recognised indication, always alongside diet changes. |
How do gut bacteria affect your blood sugar?
Prediabetes is usually defined as a fasting glucose of 100–125 mg/dL or an HbA1c of 5.7–6.4%. Behind those numbers is insulin resistance, and your gut microbes play a part in it.
Researchers are still working out which of these routes matters most, and whether microbiome testing can predict who will benefit from FMT.
Gut bacteria also influence heart health through a molecule called TMAO. See FMT and atherosclerosis.
- Short-chain fatty acidsWhen gut bacteria ferment fibre, they make butyrate and other short-chain fatty acids that help the gut release GLP-1, a hormone that supports insulin.
- Low-grade inflammationAn unbalanced microbiome can let bacterial fragments into the bloodstream, driving inflammation that makes cells resist insulin.
- Bile acidsMicrobes reshape bile acids, which act as signals that influence how the body handles glucose and fat.
- Your starting microbiome mattersIn a Dutch trial, people with lower microbiome diversity before treatment were more likely to respond to FMT.2
How common is prediabetes in India?
The ICMR-INDIAB study, which examined more than 1.1 lakh adults across every state, estimated that 15.3% of Indians, about 136 million people, have prediabetes, alongside 101 million with diabetes.4 Without action, many people with prediabetes go on to develop type 2 diabetes.
- About 11 in 100adults have diabetes (11.4%)
- About 15 in 100adults have prediabetes (15.3%)
What does the research say about FMT for prediabetes?
FMT for insulin resistance has been tested in several small randomised trials, which puts it on the third step of our evidence ladder.
- 5Guideline-recommended careRecurrent C. difficile
- 4Multiple randomised trials and meta-analyses
- 3Small randomised trialsPrediabetes evidence is here
- 2Case reports and small studies
- 1Laboratory and animal research
Level 5 shows where fully proven FMT sits today, for comparison.
Guideline-recommended care
FMT is a guideline-recommended treatment for recurrent C. difficile infection
The American Gastroenterological Association’s 2024 guideline recommends fecal microbiota-based therapy to prevent recurrent C. difficile infection in suitable adults. It is shown here as the reference point: this is what fully proven FMT looks like.3
Multiple randomised trials and meta-analyses
No large meta-analysis yet confirms a lasting benefit for prediabetes specifically.
Small randomised trials
Lean-donor FMT improved insulin sensitivity at six weeks
Eighteen men with metabolic syndrome were randomised to lean-donor or their own microbiota. Glucose uptake rose from a median 26.2 to 45.3 µmol/kg/min in the donor group.1
The benefit was temporary, and only about half responded
In a larger follow-up trial of 38 men, insulin sensitivity improved six weeks after lean-donor FMT but not at 18 weeks. Lower starting diversity predicted response.2
Oral FMT capsules plus fibre improved insulin resistance
Among 70 adults with severe obesity and metabolic syndrome, only those given FMT plus a low-fermentable fibre improved (HOMA2-IR 3.77 to 3.16 at six weeks).5
Repeated FMT with lifestyle change improved cholesterol in type 2 diabetes
In 61 obese adults with type 2 diabetes, repeated FMT increased engraftment of healthy microbes, and FMT plus lifestyle advice lowered total and LDL cholesterol and liver stiffness at 24 weeks.6
FMT with or without metformin improved insulin resistance in type 2 diabetes
A Chinese randomised study reported improved insulin resistance and body mass index after FMT, alone or combined with metformin.7
Case reports and small studies
Uncontrolled reports have largely been overtaken by the randomised trials above.
Laboratory and animal research
A large body of laboratory and animal research underpins these trials.
What the researchers concluded
“Beneficial effects of lean donor FMT are transient”
“…results so far have been inconsistent”
Our reading of the evidence
The trials point the same way: FMT can improve insulin sensitivity, but usually modestly and temporarily, and not everyone responds. No trial has shown that FMT alone prevents type 2 diabetes. The most promising approach in research pairs FMT with diet, especially fibre, and lifestyle change. For prediabetes, FMT remains investigational: diet and activity are the proven first step, and microbiome testing can help personalise that advice.
Published case reports: FMT for prediabetes
These are published research results from independent teams, not Resplice patients. They show what is possible, not what any one person should expect.
Eighteen men with metabolic syndrome in Amsterdam
Published case: Vrieze A, Gastroenterology, 2012
- Participants
- Eighteen men with metabolic syndrome, randomised to microbiota from lean donors (nine men) or their own stool (nine men), given by tube into the small intestine.
- What changed
- Six weeks later, insulin sensitivity in the donor group had risen substantially, with median glucose uptake climbing from 26.2 to 45.3 µmol/kg/min, alongside an increase in butyrate-producing gut bacteria.
- What it can't tell us
- A small, men-only study with short follow-up. A later trial by the same group found the effect had faded by 18 weeks.2
Seventy adults with severe obesity: the fibre factor
Published case: Mocanu V, Nat Med, 2021
- Participants
- Seventy adults with severe obesity and metabolic syndrome, randomised to a single dose of oral FMT capsules or placebo, each followed by a daily high- or low-fermentable fibre supplement for six weeks.
- What changed
- Only the FMT plus low-fermentable fibre group improved insulin resistance (HOMA2-IR 3.77 to 3.16), with more beneficial bacteria such as Akkermansia muciniphila. Most microbiome changes had faded by 12 weeks.
- What it can't tell us
- Participants had severe obesity rather than prediabetes alone, and the benefit was short-lived.
Who might FMT be suitable for?
May be appropriate if
- You have a recognised indication for FMT, such as recurrent C. difficile infection, alongside prediabetes
- You are taking part in an ethics-committee-approved research study of FMT for insulin resistance
- You are also making diet and activity changes, which are the proven treatment for prediabetes
- Your doctor has discussed the risks, the short-lived benefit seen in trials, and your consent in writing
Not advised if
- You have type 1 diabetes: FMT has not been studied for this here
- You are pregnant or planning pregnancy soon
- Your immune system is severely weakened
- You want FMT to replace diet, exercise or prescribed medicines such as metformin
What happens at an FMT assessment at Resplice?
Nobody is booked straight in for FMT. A typical pathway has five steps, and you can stop at any point. Your existing doctors are kept informed throughout.
Initial assessment
We review your sugar readings, HbA1c, weight, blood pressure, lipids, medicines, diet and gut symptoms.
Gut health evaluation
Blood and stool tests look for infections, inflammation or other problems that need treating first, and help decide whether FMT is appropriate at all.
Microbiome testing and treatment planning
Microbiome testing measures your gut diversity. You receive a written plan built on a fibre-focused diet and activity goals.
FMT procedure
FMT is considered only where there is a recognised indication or an approved study, and is then given by the route agreed for you.
Follow-up and long-term monitoring
We recheck fasting glucose, HbA1c, lipids and your microbiome at set intervals, with nutrition coaching in between to help the changes last.
Is FMT safe? Side effects and donor screening
Healthy donor
A healthy adult volunteer offers to donate.
Screening
Health questionnaire plus blood and stool tests.
Stool bank
Approved samples are processed and stored.
Preparation
Prepared under laboratory conditions.
Delivery
Given by colonoscopy, enema or another route.
Engraftment
Donor microbes settle and grow in the gut.
FMT is generally well tolerated when donors are carefully screened. The most common effects are short-lived bloating, cramps, loose stools or a mild fever. Rare but serious infections have been reported worldwide when donor screening was inadequate, which is why screening matters more than any other step.
People with severely weakened immune systems face higher risks, so your own health is reviewed in detail before FMT is considered, and the benefits, risks and alternatives are explained before you give written consent.
International donor-screening standards include
- A detailed health, travel and lifestyle questionnaire for every donor
- Blood tests for infections such as HIV, hepatitis and syphilis
- Stool tests for C. difficile, disease-causing bacteria, parasites and drug-resistant organisms
- Repeat testing over time, so that every batch can be traced from donor to patient
Resplice Institute’s FMT service in Hyderabad and Mumbai
Services
Clinical gut-health assessment, microbiome testing, FMT for recognised indications, post-treatment monitoring, and nutrition and lifestyle guidance.
Donor material
Supplied from Resplice Institute's stool bank. Our donor-screening protocol is available on request.
Locations
Hyderabad (Manikonda and Patancheru, Telangana) and Mumbai, Maharashtra.
Charges
Fees depend on the tests and treatment plan, and are given to you in writing before any treatment.
Questions to ask before you consider FMT
Whether you come to us or go elsewhere, these are fair questions to put to any FMT provider. A good clinic will welcome them.
- Why do you think FMT is appropriate for me, and what is the evidence for my condition?
- Is this a recognised indication for FMT, or part of an ethics-committee-approved study?
- How are donors screened, and can I see your screening protocol?
- Which route will you use, how many sessions will I need, and how do I prepare?
- Which side effects should I watch for, and who do I call if I feel unwell afterwards?
- How will we measure whether it has helped, and when?
- Should any of my current medicines change? (Never stop a medicine on your own.)
- What is the total cost, including tests and follow-up visits?
Frequently asked questions about FMT for prediabetes
Is FMT a cure for prediabetes or diabetes?
No. FMT has improved insulin sensitivity in trials, but the effect was usually temporary and it has not been shown to prevent or cure diabetes. In trials, any benefit was greatest when combined with diet changes.
How long do the effects of FMT last?
In trials, benefits were measured around six weeks after treatment. In one Dutch trial they were gone by 18 weeks, while a Hong Kong trial found repeated FMT helped healthy microbes take hold for longer.
Why does diet matter so much with FMT?
Donor microbes need the right food to survive. In a Canadian trial, FMT improved insulin resistance only in people who also took a daily fibre supplement, and a Hong Kong trial saw the best results when FMT was combined with lifestyle advice.
Will FMT help me lose weight?
Most trials found little or no weight change after FMT, although one small study reported a lower body mass index. FMT should not be thought of as a weight-loss treatment.
Can I have FMT while taking metformin?
Yes. FMT does not replace metformin or other prescribed medicines, and one randomised study tested FMT together with metformin. Do not stop any medicine without your doctor.
What tests will I need?
Usually fasting glucose, HbA1c, lipids and liver tests, blood tests for infection screening, a stool test and a microbiome analysis. We tell you exactly which ones at the first visit.
Who are stool donors and how are they screened?
Donors are healthy adult volunteers. Under international screening standards, each donor completes a detailed health questionnaire and passes blood and stool tests for infections and drug-resistant bacteria, with testing repeated over time. You are entitled to ask any FMT provider, including us, to explain their donor-screening protocol before treatment.
Where are Resplice Institute's FMT centres?
Resplice Institute’s gut microbiome and FMT service is available in two cities: Hyderabad, at our Manikonda and Patancheru centres in Telangana, and Mumbai, Maharashtra. Assessments, microbiome testing and follow-up can be arranged in either city.
How much does FMT cost in Hyderabad and Mumbai?
Cost depends on the tests you need, the delivery route and the number of sessions in your plan. We give you a written estimate after the first consultation, before any treatment begins.
Contact and appointments
For an appointment, please bring your latest fasting glucose, HbA1c and lipid reports and a list of current medicines.
Our FMT centres
Hyderabad: Manikonda
Vaishnavione, 3rd Floor, above Vijetha Supermarket, Shivapuri Colony, Manikonda, Hyderabad, Telangana 500089Hyderabad: Patancheru
RM/6 5-98, beside Rainbow Meadows, Krishna Reddy Pet, Patelguda, Patancheru, Telangana 502319Mumbai
[Full clinic address and PIN code]Mumbai, Maharashtra
References
- Vrieze A, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913–916. doi.org/10.1053/j.gastro.2012.06.031
- Kootte RS, et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 2017;26(4):611–619. pubmed.ncbi.nlm.nih.gov/28978426/
- Peery AF, et al. AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases. Gastroenterology. 2024;166(3):409–434. doi.org/10.1053/j.gastro.2024.01.008
- Anjana RM, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7). doi.org/10.1016/S2213-8587(23)00119-5
- Mocanu V, et al. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nat Med. 2021;27(7):1272–1279. pubmed.ncbi.nlm.nih.gov/34226737/
- Ng SC, et al. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. Gut. 2022;71(4):716–723. doi.org/10.1136/gutjnl-2020-323617
- Wu Z, et al. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: a randomized, controlled, prospective study. Front Cell Infect Microbiol. 2023;12:1089991. doi.org/10.3389/fcimb.2022.1089991